Entecavir Granules(Hunan Warrant Pharma)

恩替卡韦颗粒（湖南华纳大药厂）

Report date: 2025/07/18 16:44:05

Base Information

Drug NameEntecavir Granules(Hunan Warrant Pharma)
Drug Alias NameEntecavirum恩替卡伟ENTECAVIR恩替卡韦一水化合物Cavir +[7] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionHBV DNA Polymerase inhibitorsReverse transcriptase inhibitors
TargetsReverse transcriptaseHBV DNA Polymerase
Therapy Area/IndicationsHepatitis B, Chronic
Global Approved IndicationsHepatitis B, Chronic
Approved Indications in ChinaHepatitis B, Chronic
Original Approved Country/TerritoryMainland China
Original Approved Date2021/09/09
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHunan Warrant Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHunan Warrant Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG